Russian Journal of General Chemistry

, Volume 89, Issue 7, pp 1485–1490 | Cite as

Design, Synthesis, and Anticancer Evaluation of 2-{3-{4-[(5-Aryl-1,2,4-oxadiazol-3-yl)methoxy]phenyl}isoxazol-5-yl}-N-(3,4,5-trimethylphenyl)thiazol-4-amine Derivatives

  • T. Yakantham
  • R. Sreenivasulu
  • R. R. RajuEmail author


A series of new 2-{3-{4-[(5-aryl-1,2,4-oxadiazol-3-yl)methoxy]phenyl}isoxazol-5-yl}-N-(3,4,5-tri-methylphenyl)thiazol-4-amine derivatives is synthesized, and the structures of products are confirmed by 1H and 13C NMR, and mass spectra. The new compounds are tested for their anticancer activity against human cancer cell lines: MCF-7 (breast), A549 (lung), Du-145 (prostate), and MDA MB-231 (breast) by using MTT assay and etoposide as a standard reference. All compounds demonstrate good to moderate activity on all cell lines.


dasatinib proxazole 1,2,4-oxadiazole anticancer activity MTT assay 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mayhoub, A.S., Khaliq, M., and Botting, C., Bioorg. Med. Chem., 2011, vol. 19, p. 3845. doi CrossRefGoogle Scholar
  2. 2.
    Jalilian, A.R., Sattari, S., Bineshmarvasti, M., Shafiee, A., and Daneshtalab, M., Arch. Pharm. Med. Chem., 2000, vol. 333, p. 347.doi;2-6 CrossRefGoogle Scholar
  3. 3.
    Liu, C.L., Li, L., and Li, Z.M., Bioorg. Med. Chem., 2004, vol. 12, p. 2825. doi CrossRefGoogle Scholar
  4. 4.
    Hutchinson, I., Chua, M.S., Browne, H.L., Trapani, V., Bradshaw, T.D., Westwell, A. D., and Stevens, M.F.G., J. Med. Chem., 2001, vol. 44, p. 1446. doi CrossRefGoogle Scholar
  5. 5.
    Dawood, K.M., Gawad, H.A., Rageb, E.A., Ellithey, M., and Mohamed, H.A., Bioorg. Med. Chem., 2006, vol. 14, p. 3672. doi CrossRefGoogle Scholar
  6. 6.
    Vicini, P., Geronikaki, A., Anastasia, K., Incerti, M., and Zani, F., Bioorg. Med. Chem., 2006, vol. 14, p. 3859. doi CrossRefGoogle Scholar
  7. 7.
    Kumar, A., Rajput, C.S., and Bhati, S.K., Bioorg. Med. Chem., 2007, vol. 15, p. 3089. doi CrossRefGoogle Scholar
  8. 8.
    Shiradkar, M.R., Murahari, K.K., Gangadasu, H.R., Suresh, T., Kalyan, C.A., Panchal, D., Kaur, R., Burange, P., Ghogare, J., Mokalec, V., and Raut, M., Bioorg. Med. Chem., 2007, vol. 15, p. 3997. doi CrossRefGoogle Scholar
  9. 9.
    Cohen, A., Verhaeghe, P., Crozet, M.D., Hutter, S., Rathelot, P., Vanelle, P., and Azas, N., Eur. J. Med. Chem., 2012, vol. 55, p. 315.doi CrossRefGoogle Scholar
  10. 10.
    Shih, M.H., and Ying, K.F., Bioorg. Med. Chem., 2004, vol. 12, p. 4633.doi CrossRefGoogle Scholar
  11. 11.
    Abruzzese, E., Breccia, M., and Latagliata, R., Bio. Drugs, 2014, vol. 28, p. 17. doi Google Scholar
  12. 12.
    Pace, A., and Pierro, P., Org. Biomol. Chem., 2009, vol. 7, p. 4337. doi CrossRefGoogle Scholar
  13. 13.
    Pace A., Buscemi, S., and Vivona, N., Org. Prep. Proced. Int., 2005, vol. 37, p. 447. doi CrossRefGoogle Scholar
  14. 14.
    Zhang, H.Z., Kasibhatla, S., and Kuemmerle, J., J. Med. Chem., 2005, vol. 48, p. 5215. doi CrossRefGoogle Scholar
  15. 15.
    Axel, K. and Jürgen, E., Pharmaceutical Substances: Syntheses, Patents, Applications, Thieme Chemistry, Stuttgart, Germany, 2001.Google Scholar

Copyright information

© Pleiades Publishing, Ltd. 2019

Authors and Affiliations

  1. 1.Department of ChemistryAcharya Nagarjuna UniversityNagarjuna NagarIndia
  2. 2.Department of ChemistryUniversity College of Engineering (Autonomous), Jawaharlal Nehru Technological UniversityKakinadaIndia

Personalised recommendations